SynthesisAnnals of medicine2025

Treatment consequence and adverse events of cyclin-dependent kinase 4/6 inhibitors on patients with hormone receptor-positive, HER2-negative metastatic breast cancer: a systematic review and meta-analysis.

Hsiang-Ying Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.